UNSW scientist Justin Gooding and a separate team from the Kirby Institute have been honoured with prestigious Eureka Prizes for efforts to support the next generation of researchers and combat the scourge of scabies.
The Kirby Institute at UNSW has welcomed the Therapeutic Goods Administration's approval of antiretroviral drug Truvada as pre-exposure prophylaxis (PrEP) in Australia.
HIV cells in the body of a person receiving antiretroviral treatment become activated 24 times less frequently than previously thought, new research from UNSW's Kirby Institute shows.
The Kirby Insitute at UNSW has launched a feasibility study to examine whether HIV negative people can take combination drug therapy to reduce their risk of acquiring the virus.
Work by PhD graduate Dr Simon Graham to encourage Indigenous boys to be tested for sexually transmissable diseases is having a positive impact in Aboriginal communities aross NSW.
UNSW will lead a world-first study to evaluate the effectiveness of a one tablet per day hepatitis C treatment as a means of preventing the spread of the virus in prisons.
French Nobel Laureate Francoise Barré-Sinoussi has been awarded a UNSW honorary doctorate of medicine in recognition of her contribution to HIV/AIDS research.
Those rare people who never fall ill with AIDS despite being infected with HIV could be a key to developing a vaccine or even a cure, Nobel prize-winning virologist Françoise Barré-Sinoussi will tell a UNSW symposium.
Some of the world’s leading researchers in HIV will converge on UNSW for the launch of the Kirby Institute’s new facilities and a symposium on the challenges in infectious disease.
![IMG 2811[1] 1](https://newsroom.unsw.edu.au/sites/default/files/styles/teaser_thumbnail/public/thumbnails/image/IMG_2811%5B1%5D_1_3_1.JPG?itok=xw7rlYe3 "IMG 2811[1] 1")
